Literature DB >> 27732698

The Epidemiology and Clinicopathological Features of Basal Cell Carcinoma in Patients 80 Years and Older: A Systematic Review.

Satish F K Lubeek1, Lieke J van Vugt1, Katja K H Aben2, Peter C M van de Kerkhof1, Marie-Jeanne P Gerritsen1.   

Abstract

Importance: The number of very elderly (≥80 years) is rapidly growing worldwide. Basal cell carcinoma (BCC) are common in this age group and treatment is often challenging in this population. Objective: Obtaining an overview of the epidemiology and clinicopathological features of BCC in the very elderly to guide clinicians and policy makers. Evidence Review: A systematic review of literature was performed using PubMed, Excerpta Medica Database (EMBASE), and the Cochrane Library. Study selection, quality assessment, and data extraction was performed by 2 independent reviewers. For quality assessment (including the risk of bias) the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) checklist was used, combined with the Quality Rating Scheme for Studies and Other Evidence. Data were described though a narrative synthesis and tabulation. Findings: Of 13 628 studies identified, 83 studies were included and quality assesment was performed for 76 studies; 27 studies (representing >350 000 patients) were found that included age-specific incidence rates of BCC in the very elderly. High and increasing incidence rates of BCC in the very elderly were found ranging from 13 to 12 112 per 100 000 person-years, strongly depending on factors like study population and clinical setting. Basal cell carcinoma in the very elderly were more common in men, mostly of the nodular subtype, and located in the head and neck region. Interpretation and generalization of the data was limited by the heterogeneity of study populations, methods, and outcomes. Data concerning impact on health-related quality of life (HRQoL) and prognostication were scarce. Conclusions and Relevance: The incidence of BCC among the very elderly is high and increasing. Epidemiologic and clinicopathological data from current literature provide only limited guidance in clinical decision making owing to heterogeneity and scarcity. Future research should focus more specifically on BCC in the very elderly, together with prognostication and their relation with HRQoL in both the short and longer term.

Entities:  

Mesh:

Year:  2017        PMID: 27732698     DOI: 10.1001/jamadermatol.2016.3628

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN: 2168-6068            Impact factor:   10.282


  10 in total

1.  Functional status and survival in patients ≥85 years of age who have keratinocyte carcinoma: A retrospective cohort study.

Authors:  Niki B Vora; Karen L Connolly; Stephen Dusza; Anthony M Rossi; Kishwer S Nehal; Erica H Lee
Journal:  J Am Acad Dermatol       Date:  2020-04-19       Impact factor: 11.527

2.  Aging and the treatment of basal cell carcinoma.

Authors:  Shreya Sreekantaswamy; Justin Endo; Amy Chen; Daniel Butler; Lily Morrison; Eleni Linos
Journal:  Clin Dermatol       Date:  2019-06-16       Impact factor: 3.541

Review 3.  Assessing the compliance of systematic review articles published in leading dermatology journals with the PRISMA statement guidelines: A systematic review.

Authors:  Buket Gundogan; Naeem Dowlut; Shivanchan Rajmohan; Mimi R Borrelli; Mirabel Millip; Christos Iosifidis; Yagazie Z Udeaja; Ginimol Mathew; Alexander Fowler; Riaz Agha
Journal:  JAAD Int       Date:  2020-09-07

4.  Natural history of lesions suspicious for basal cell carcinoma in older adults in Ikaria, Greece.

Authors:  M R Wehner; N Dalma; C Landefeld; A Pare-Anastasiadou; I Koutelidas; M M Chren; N Aji; C E Teng; B A Koenig; J Tang; K Covinsky; E Linos
Journal:  Br J Dermatol       Date:  2018-07-12       Impact factor: 9.302

5.  Comorbidity scores associated with limited life expectancy in the very elderly with nonmelanoma skin cancer.

Authors:  Emma M Rogers; Karen L Connolly; Kishwer S Nehal; Stephen W Dusza; Anthony M Rossi; Erica Lee
Journal:  J Am Acad Dermatol       Date:  2017-12-27       Impact factor: 11.527

Review 6.  Effect of Patient Characteristics on Treatment Decisions Regarding Keratinocyte Carcinoma in Elderly Patients: A Review of the Current Literature.

Authors:  Marjolijn S Haisma; Linda Bras; Mehran Alizadeh Aghdam; Jorrit B Terra; Boudewijn E C Plaat; Emöke Rácz; Gyorgy B Halmos
Journal:  Acta Derm Venereol       Date:  2020-06-18       Impact factor: 3.875

Review 7.  Treatment of keratinocyte carcinoma in elderly patients - a review of the current literature.

Authors:  A J G Leus; M Frie; M S Haisma; J B Terra; B E C Plaat; R J H M Steenbakkers; G B Halmos; E Rácz
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-03-30       Impact factor: 6.166

8.  Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: First results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant Vismodegib in Locally Advanced Basal Cell Carcinoma.

Authors:  Nicolas Bertrand; Pierre Guerreschi; Nicole Basset-Seguin; Philippe Saiag; Alain Dupuy; Sophie Dalac-Rat; Véronique Dziwniel; César Depoortère; Alain Duhamel; Laurent Mortier
Journal:  EClinicalMedicine       Date:  2021-04-26

Review 9.  Skin Cancer Epidemics in the Elderly as An Emerging Issue in Geriatric Oncology.

Authors:  Simone Garcovich; Giuseppe Colloca; Pietro Sollena; Bellieni Andrea; Lodovico Balducci; William C Cho; Roberto Bernabei; Ketty Peris
Journal:  Aging Dis       Date:  2017-10-01       Impact factor: 6.745

10.  Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: An analysis of the Global Burden of Disease Study 2019.

Authors:  Wei Zhang; Wen Zeng; Aofei Jiang; Zhi He; Xiaoping Shen; Xian Dong; Jianglong Feng; Hongguang Lu
Journal:  Cancer Med       Date:  2021-06-09       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.